3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl acrylate

Acute Toxicity: inhalation

Administrative data

Endpoint:

acute toxicity: inhalation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

May 8 to July 8, 2003

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: guideline test for read across, well documented

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2003

Report date:

2003

Materials and methods

Test guideline

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 403 (Acute Inhalation Toxicity)

Deviations:

no

Principles of method if other than guideline:

Two groups of 6 male rats each were exposed to aerosol atmospheres of test article in air. Rats were exposed nose-only for a single, 4-hour period. Following exposure, 3 rats from the 0.10 mg/L exposure were retained for a 1-day recovery period; the remaining 3 rats were retained for a 14-day recovery period. Rats from the 1.8 mg/L exposure were retained for a 14-day recovery period.

GLP compliance:

not specified

Test type:

standard acute method

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

H-25777

IUPAC Name:

H-25777

Test material form:

other: solid

Details on test material:

a pale yellow solid
Stability: The test substance appeared to be stable under the conditions of the study; no evidence of instability was observed.

Specific details on test material used for the study:

Composition of material tested, designation H-25777, Lot-No. 478
1.16% F(CF2CF2)3CH2CH2OCOCH=CH2 [CAS# 17527-29-6]
53.29% F(CF2CF2)4CH2CH2OCOCH=CH2 [CAS# 27905-45-9]
25.09% F(CF2CF2)5CH2CH2OCOCH=CH2 [CAS# 17741-60-5]
9.26% F(CF2CF2)6CH2CH2OCOCH=CH2 [CAS# 34395-24-9]
2.58% F(CF2CF2)7CH2CH2OCOCH=CH2 [CAS# 34362-49-7]
0.72% F(CF2CF2)8CH2CH2OCOCH=CH2 [CAS# 65150-93-8]
0.20% F(CF2CF2)9CH2CH2OCOCH=CH2 [CAS# 65104-64-5]
Aspect: Pale yellow liquid

Test animals

Species:

rat

Strain:

Crj: CD(SD)

Sex:

male

Details on test animals or test system and environmental conditions:

B. Test Species
Young adult, male Crl:CD®(SD)IGS BR rats were received from Charles River Laboratories, Inc., Raleigh, North Carolina. The rats were approximately 7 or 8 weeks old on the day of arrival.
Rats have historically been used in safety evaluation studies for inhalation toxicity testing. The Crl:CD®(SD)IGS BR rat was selected based on consistently acceptable health status and on extensive experience with the strain at Haskell Laboratory.
C. Animal Husbandry
1. Quarantine
Rats were quarantined after arrival for 6 days prior to testing. During the quarantine period, rats were weighed and observed for clinical signs of disease 3 times.
2. Animal Selection
Prior to each exposure, 6 male rats were selected for use on the study from the rats that were released from quarantine. The selected animals had been gaining weight at a normal rate and demonstrated no overt signs of disease, and were the appropriate age and body weight. No attempt was made to randomly group animals.
3. Identification
Each rat was assigned an animal number which was recorded on a card affixed to the cage. Prior to exposure, the tail of each animal and cage card were marked with water-insoluble pens so that each animal could be identified after exposure and during the recovery period.
4. Housing
Except during exposure, rats were housed singly in stainless steel, wire-mesh cages suspended above cage boards.
5. Animal Room Environment
Rats were housed in proximity to the inhalation chambers. Animal rooms were maintained at a temperature of 18 - 26 °C (targeted to 22 - 24 ºC) and a relative humidity of 30 - 70% (targeted to 40-60%). Animal rooms were artificially illuminated (fluorescent light) on an approximate 12 hour light/dark cycle. Excursions outside of these ranges were of insufficient magnitude and/or duration to have adversely affected the validity of the study.
6. Feed and Water
Except during exposure, PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002 and tap water were available ad libitum.
7. Animal Health and Environmental Monitoring Program
As specified in the Haskell Laboratory animal health and environmental monitoring program, the following procedures are performed periodically to ensure that contaminant levels are below those that would be expected to impact the scientific integrity of the study:
• Water samples are analyzed for total bacterial counts, and the presence of coliforms, lead, and other contaminants.
• Feed samples are analyzed for total bacterial, spore, and fungal counts.
• Samples from freshly washed cages and cage racks are analyzed to ensure adequate sanitation by the cagewashers.
Certified animal feed is used, guaranteed by the manufacturer to meet specified nutritional requirements and not to exceed stated maximum concentrations of key contaminants, including specified heavy metals, aflatoxin, chlorinated hydrocarbons, and organophosphates. The presence of these contaminants below the maximum concentration stated by the manufacturer would not be expected to impact the integrity of the study.
The animal health and environmental monitoring program is administered by the attending laboratory animal veterinarian. Evaluation of these data did not indicate any conditions that affected the validity of the study.

Administration / exposure

Route of administration:

inhalation: vapour

Type of inhalation exposure:

nose only

Vehicle:

air

Details on inhalation exposure:

Inhalation Exposure System
1. Atmosphere Generation
Chamber atmospheres were generated by aerosolization of the solid test substance in air with a glass, round-bottom flask placed in a heating mantle. The flask was heated to approximately 100 ºC to melt the test substance. Filtered, high-pressure air, metered into the flask by a Brooks model 5851E mass flow controller, carried the evolved vapor through heated glass tubing. For the 0.10 mg/L exposure, 2 chambers were used. The vapor passed from the heated tubing into the first chamber where a condensation aerosol was formed. The aerosol then passed into the second chamber for animal exposure. For the 1.8 mg/L exposure, the vapor passed from the heated tubing in the exposure chamber where an aerosol was formed.
Test atmospheres were exhausted through an MSA charcoal/HEPA filter cartridge prior to discharge into the fume hood.
2. Chamber Construction and Design
The exposure chambers were constructed of glass (cylindrical) with a nominal internal volume of 34 L. A baffle inside each chamber promoted uniform distribution of the test atmosphere.
3. Exposure Mode
During exposure, animals were individually restrained in perforated stainless steel cylinders with conical nose pieces. The restrainers were inserted into a polymethylmethacrylate faceplate which was attached to the exposure chamber so that the nose of each animal extended into the exposure chamber.
Characterization of Chamber Atmosphere
1. Test Substance Sampling and Analysis
The atmospheric concentration of H-25777 was determined by gravimetric analysis at approximately 30-minute intervals during each exposure. Known volumes of chamber atmosphere were drawn from the sampling port through a 25 mm filter cassette that contained a pre-weighed Gelman glass fiber (Type A/E) filter. The filters were weighed on a Cahn model C-33 Microbalance®. The atmospheric concentration of H-25777 was calculated from the difference in the pre- and post-sampling filter weights divided by the volume of chamber atmosphere sampled.
2. Particle Size Determination
A sample to determine particle size distribution (mass median aerodynamic diameter and percent particles less than 1, 3, or 10 µm diameter) was taken during each exposure with a Sierra® Series 210 cyclone preseparator/Cascade impactor and Sierra® series 110 constant flow air sampler.
3. Environmental Monitoring
Chamber airflow was set at the beginning of each exposure to achieve at least 10 air changes per hour. The airflow was monitored continually with a calibrated Brooks model 5851E mass flow controller and recorded initially and whenever changes were made during each exposure.
Chamber temperature was targeted at 22 ±2 °C. The temperature was monitored continually with a digital traceable thermometer and recorded 3 times during each exposure. Chamber relative humidity was targeted at 50 ±10%. The relative humidity was measured with an Omega model RH5100C digital psychrometer and recorded 3 times during each exposure. Chamber oxygen concentration was targeted to be at least 19%. The oxygen concentration was measured with a Biosystems model 3100R oxygen analyzer and recorded 3 times during each exposure.

Analytical verification of test atmosphere concentrations:

yes

Duration of exposure:

4 h

Concentrations:

0.1 and 1.8 mg/l

No. of animals per sex per dose:

3

Control animals:

no

Details on study design:

Two groups of 6 male rats each were exposed to aerosol atmospheres of H-25777 in air. Rats were exposed nose-only for a single, 4-hour period. Following exposure, 3 rats from the 0.10 mg/L exposure were retained for a 1-day recovery period; the remaining 3 rats were retained for a 14-day recovery period. Rats from the 1.8 mg/L exposure were retained for a 14-day recovery period.
Rats were approximately 8 weeks old and weighed between 258 and 279 grams at the time of exposure.
Animals were observed for mortality 4 times during each exposure and observed for mortality and clinical signs of toxicity immediately after exposure. During the recovery period, all rats were observed each day for mortality. Rats were weighed and observed for clinical signs of toxicity on the day following exposure and at least twice more during the recovery period. At the end of both recovery periods, all rats from the 0.10 mg/L group were sacrificed for anatomic pathology evaluation. All rats from the 1.8 mg/L exposure were sacrificed by carbon dioxide asphyxiation and discarded.
Anatomic Pathology Evaluation
All animals from the 0.10 mg/L exposure underwent a gross pathology examination at sacrifice. In addition, the lungs, trachea, nose (4 cross sections), larynx, and pharynx were processed for histopathology and microscopically examined. Lung weights were obtained for the 3 animals sacrificed 1 day after exposure to 0.10 mg/L.

Statistics:

no applicable

Results and discussion

Effect levels

Sex:

male

Dose descriptor:

LC50

Effect level:

> 1.8 mg/L air (analytical)

Based on:

test mat.

Exp. duration:

4 h

Remarks on result:

other: Other than slight body weight losses measured in 3 of 6 rats one day after exposure to 1.8 mg/L of H-25777, there were no significant clinical signs observed in the exposed rats at either test concentration.

Mortality:

No deaths occurred during the study.

Clinical signs:

other: No clinical signs of toxicity were observed during the remainder of the recovery period.

Body weight:

No body weight losses were observed in rats exposed to 0.10 mg/L immediately after exposure or after the 14-day recovery period.
Three of 6 rats exposed to 1.8 mg/L showed slight weight loss (<10 grams) on the day following exposure, followed by a normal weight gain rate (approximately 5- 10 g/day) for the remainder of the recovery period.

Gross pathology:

There were no appreciable differences between the 2 groups. The alveolar hemorrhages were very minimal, and were likely agonal changes occurring at the time of sacrifice.
Lung weights in 3 rats sacrificed 1 day after exposure to H-25777 at 0.10 mg/L did not appear to be different from control rats of similar weights in a recent Haskell Laboratory inhalation study.
Although no concurrent controls were provided, the changes present in the tissues examined were considered to be of the type and severity expected in this strain of rats, and none of them appeared to be the result of treatment.

Other findings:

Exposure Conditions
Animals were exposed to H-25777 at mean concentrations of 0.10 or 1.8 mg/L. The atmospheres generated in this study were considered to be marginally respirable in rats, as the mass median aerodynamic diameters (MMAD) were 5.8 and 6.8 µm. Several attempts were made to produce a smaller, more respirable aerosol size; however, it appeared that this could not be accomplished at these high concentrations due to the condensation aerosol forming large particle agglomerates.
Chamber temperature ranged from 23 to 24 °C, chamber relative humidity ranged from 46 to 68%, chamber airflow ranged from 15 to 25 L/min, and the oxygen concentration was 21%.

Applicant's summary and conclusion

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

Under the conditions of this study, it can be concluded that LC50 of test article is considered to be greater than 1.8 mg/L after nose-only for a single, 4-hour exposure.
However, the mass median aerodynamic diameter (MMAD) of the tested aerosol at this concentration was 6.8 µm. Targeted MMADs in inhalation studies are from 1 - 4 µm to allow maximum lung exposure. Several attempts were made to produce smaller, more respirable aerosol size; however, it appeared that this could not be accomplished at these high concentrations due to the condensation aerosol forming large particle agglomerates. Thus the inhalation hazard cannot be determined since the aerosols formed were not respirable to the rats, particularly the pulmonary region.

Executive summary:

The study was performed to determine a 4-hour inhalation approximate lethal concentration (ALC) of test article in male rats. Two groups of 6 male rats each were exposed to aerosol atmospheres of test article in air. Rats were exposed nose-only for a single, 4-hour period. Following exposure, 3 rats from the 0.10 mg/L exposure were retained for a 1-day recovery period. Rats from the 1.8 mg/L exposure were retained for a 14-day recovery period. At the end of both recovery periods, all rats from the 0.10 mg/L group were sacrificed for anatomic pathology evaluation. All rats from the 1.8 mg/L exposure were sacrificed by carbon dioxide asphyxiation and discarded. Other than slight body weight losses measured in 3 of 6 rats one day after exposure to 1.8 mg/L of H-25777, there were no significant clinical signs observed in the exposed rats at either test concentration. Histological examination of rats exposed to 0.10 mg/L showed no treatment- related effects.

Therefore, the LC50 of test article is considered to be greater than 1.8 mg/L based on the results of this study.

However, the mass median aerodynamic diameter (MMAD) of the tested aerosol at this concentration was 6.8 µm. Targeted MMADs in inhalation studies are from 1 - 4 µm to allow maximum lung exposure. Several attempts were made to produce smaller, more respirable aerosol size; however, it appeared that this could not be accomplished at these high concentrations due to the condensation aerosol forming large particle agglomerates. Thus the inhalation hazard cannot be determined since the aerosols formed were not respirable to the rats, particularly the pulmonary region.